Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'

被引：0
|
作者：
Arits, A. [1 ]
Nelemans, P. [1 ]
Kelleners-Smeets, N. [1 ]
机构：
[1] Maastricht Univ Med Ctr, Dept Dermatol, NL-6229 HX Maastricht, Netherlands
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2015年 / 172卷 / 01期
关键词：
D O I：
10.1111/bjd.13565
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [41] Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial (vol 386, pg 974, 2015)
    Le Page, E.
    Veillard, D.
    Laplaud, D. A.
    LANCET, 2016, 387 (10016): : 340 - 340
  • [42] Clinical and cost-effectiveness of one-session treatment (OST) versus multisession cognitive-behavioural therapy (CBT) for specific phobias in children: protocol for a non-inferiority randomised controlled trial
    Wright, Barry D.
    Cooper, Cindy
    Scott, Alexander J.
    Tindall, Lucy
    Ali, Shehzad
    Bee, Penny
    Biggs, Katie
    Breckman, Trilby
    Davis, Thompson E., III
    Gega, Lina
    Hargate, Rebecca Julie
    Lee, Ellen
    Lovell, Karina
    Marshall, David
    McMillan, Dean
    Teare, M. Dawn
    Wilson, Jonathan
    BMJ OPEN, 2018, 8 (08):
  • [43] Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
    Brown, Janet E.
    Royle, Kara-Louise
    Gregory, Walter
    Ralph, Christy
    Maraveyas, Anthony
    Din, Omar
    Eisen, Timothy
    Nathan, Paul
    Powles, Tom
    Griffiths, Richard
    Jones, Robert
    Vasudev, Naveen
    Wheater, Matthew
    Hamid, Abdel
    Waddell, Tom
    McMenemin, Rhona
    Patel, Poulam
    Larkin, James
    Faust, Guy
    Martin, Adam
    Swain, Jayne
    Bestall, Janine
    McCabe, Christopher
    Meads, David
    Goh, Vicky
    Wah, Tze Min
    Brown, Julia
    Hewison, Jenny
    Selby, Peter
    Collinson, Fiona
    LANCET ONCOLOGY, 2023, 24 (03): : 213 - 227
  • [44] Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial (Lancet 2015; 386: 974-981)
    Jastrzebski, Karol
    AKTUALNOSCI NEUROLOGICZNE, 2016, 16 (02): : 109 - 111
  • [45] Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial
    Winston, Alan
    Post, Frank A.
    DeJesus, Edwin
    Podzamczer, Daniel
    Di Perri, Giovanni
    Estrada, Vicente
    Raffi, Francois
    Ruane, Peter
    Peyrani, Paula
    Crofoot, Gordon
    Mallon, Patrick W. G.
    Castelli, Francesco
    Yan, Mingjin
    Cox, Stephanie
    Das, Moupali
    Cheng, Andrew
    Rhee, Martin S.
    LANCET HIV, 2018, 5 (04): : E162 - E171
  • [46] Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)
    Barrera, Carlos M.
    Mykietiuk, Analia
    Metev, Hristo
    Nitu, Mimi Floarea
    Karimjee, Najumuddin
    Doreski, Pablo Alexis
    Mitha, Ismail
    Tanaseanu, Cristina Mihaela
    Molina, Joseph McDermott
    Antonovsky, Yuri
    Van Rensburg, Dirkie Johanna
    Rowe, Brian H.
    Flores-Figueroa, Jose
    Rewerska, Barbara
    Clark, Kay
    Keedy, Kara
    Sheets, Amanda
    Scott, Drusilla
    Horwith, Gary
    Das, Anita F.
    Jamieson, Brian
    Fernandes, Prabhavathi
    Oldach, David
    LANCET INFECTIOUS DISEASES, 2016, 16 (04): : 421 - 430
  • [47] Acute treatment of moderate to severe depression with hypericum extract WS 55 70 (St John's wort): Randomised controlled double blind non-inferiority trial versus paroxetine (vol 330, pg 503, 2005)
    Szegedi, A
    BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7494): : 759 - 759
  • [48] Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
    Gallant, Joel
    Lazzarin, Adriano
    Mills, Anthony
    Orkin, Chloe
    Podzamczer, Daniel
    Tebas, Pablo
    Girard, Pierre-Marie
    Brar, Indira
    Daar, Eric S.
    Wohl, David
    Rockstroh, Juergen
    Wei, Xuelian
    Custodio, Joseph
    White, Kirsten
    Martin, Hal
    Cheng, Andrew
    Quirk, Erin
    LANCET, 2017, 390 (10107): : 2063 - 2072
  • [49] Concurrent chemotherapy and external radiation therapy: An open label non-inferiority phase III randomized controlled trial of weekly versus three weekly cisplatin and radical radiotherapy in locally advanced head and neck squamous cell carcinoma: CONCERT trial
    Sharma, A.
    Chaudhary, M. K.
    Thakar, A.
    Bhaskar, S.
    Sikka, K.
    Pramanik, R.
    Biswas, A.
    Singh, C. A.
    Sahoo, R. K.
    Deo, S.
    Kumar, R.
    Thulkar, S.
    Kakkar, A.
    Seth, S.
    Sreenivas, V.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] A novel nano-iron supplement versus standard treatment for iron deficiency anaemia in children 6-35 months (IHAT-GUT trial): a double-blind, randomised, placebo-controlled non-inferiority phase II trial in The Gambia
    Mohammed, Nuredin I.
    Wason, James
    Mendy, Thomas
    Nass, Stefan A.
    Ofordile, Ogochukwu
    Camara, Famalang
    Baldeh, Bakary
    Sanyang, Chilel
    Jallow, Amadou T.
    Hossain, Ilias
    Faria, Nuno
    Powell, Jonathan J.
    Prentice, Andrew M.
    Pereira, Dora I. A.
    ECLINICALMEDICINE, 2023, 56
12345